Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 19, 2015
Evaluation of pedometry as a patient-centered outcome in patients undergoing hematopoietic cell transplant (HCT): a comparison of pedometry and patient reports of symptoms, health, and quality of lifeAntonia V Bennett, Bryce B Reeve, Ethan M Basch, et al.The Oncologist|June 3, 2024
Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevanceJonathan D Sorah, Allison M Deal, Sophia I Stein, et al.Cancer Journal (Sudbury, Mass.)|July 30, 2011
Electronic toxicity monitoring and patient-reported outcomesEthan M Basch, Bryce B Reeve, Sandra A Mitchell, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2016
Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Benjamin Arnold, Sandra A Mitchell, Lauren Lent, et al.Bone Marrow Transplantation|March 22, 2016
Personalized home-based interval exercise training may improve cardiorespiratory fitness in cancer patients preparing to undergo hematopoietic cell transplantationW A Wood, B Phillips, A E Smith-Ryan, et al.JAMA Otolaryngology-- Head & Neck Surgery|May 6, 2016
Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck CancerAaron D Falchook, Rebecca Green, Mary E Knowles, et al.Plos One|December 31, 2021
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancerStephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.Plos One|June 21, 2021
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancerStephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.Journal of Pain and Symptom Management|January 8, 2017
Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with CancerBryce B Reeve, Molly McFatrich, Laura C Pinheiro, et al.Advances in Radiation Oncology|July 26, 2017
Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility studyAaron D Falchook, Gregg Tracton, Lori Stravers, et al.Pageof 8